SurgePays (NASDAQ:SURG – Get Free Report) had its price target lowered by Ascendiant Capital Markets from $9.50 to $9.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the medical equipment provider’s stock.
SurgePays Price Performance
Shares of SURG stock opened at $1.47 on Wednesday. The firm’s 50-day moving average is $2.35 and its two-hundred day moving average is $3.57. SurgePays has a 12 month low of $1.33 and a 12 month high of $9.23. The company has a debt-to-equity ratio of 0.07, a current ratio of 7.38 and a quick ratio of 6.11. The company has a market capitalization of $28.54 million, a PE ratio of 1.28 and a beta of 0.91.
SurgePays (NASDAQ:SURG – Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The medical equipment provider reported ($0.66) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.49). The firm had revenue of $15.09 million for the quarter, compared to analysts’ expectations of $9.02 million. SurgePays had a negative net margin of 1.36% and a negative return on equity of 3.97%. Analysts predict that SurgePays will post -1.06 earnings per share for the current year.
Insider Buying and Selling
Institutional Investors Weigh In On SurgePays
Several large investors have recently added to or reduced their stakes in the business. Jump Financial LLC grew its stake in shares of SurgePays by 44.7% in the fourth quarter. Jump Financial LLC now owns 16,500 shares of the medical equipment provider’s stock worth $106,000 after acquiring an additional 5,100 shares in the last quarter. Victory Capital Management Inc. purchased a new position in SurgePays in the fourth quarter valued at $106,000. Vanguard Group Inc. grew its stake in SurgePays by 8.2% during the 1st quarter. Vanguard Group Inc. now owns 505,380 shares of the medical equipment provider’s stock worth $1,946,000 after purchasing an additional 38,195 shares in the last quarter. Oxford Asset Management LLP purchased a new stake in SurgePays during the 4th quarter worth about $71,000. Finally, Truvestments Capital LLC raised its position in SurgePays by 3,541.8% in the 1st quarter. Truvestments Capital LLC now owns 58,123 shares of the medical equipment provider’s stock valued at $224,000 after purchasing an additional 56,527 shares in the last quarter. 6.94% of the stock is owned by hedge funds and other institutional investors.
About SurgePays
SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.
Featured Articles
- Five stocks we like better than SurgePays
- Most Volatile Stocks, What Investors Need to Know
- 3 Leveraged ETFs to Multiply Returns
- The Basics of Support and Resistance
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- 3 Best Fintech Stocks for a Portfolio Boost
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for SurgePays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurgePays and related companies with MarketBeat.com's FREE daily email newsletter.